Incyte Corp. (INCY) Plunged To A New Low After Phase 3 Study Failed

Incyte Corp. (INCY) and Merck (MRK) announced Friday morning that their Phase 3 study of Incyte's epacadostat in combination with Merck's KEYTRUDA did not meet the primary endpoint.

from RTT - Before the Bell https://ift.tt/2H4gN2D
via IFTTT